|
|
Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns |
Jaffar A. Al-Tawfiq1,2, Ali S. Omrani3, Ziad A. Memish4,5() |
1. Johns Hopkins Aramco Healthcare, Dhahran 31311, Kingdom of Saudi Arabia 2. Indiana University School of Medicine, Indianapolis, IN 46202-3082, USA 3. Department of Medicine, Section of Infectious Diseases, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Kingdom of Saudi Arabia 4. Ministry of Health, Riyadh 11514, Kingdom of Saudi Arabia 5. College of Medicine, Alfaisal University, Riyadh 11533, Kingdom of Saudi Arabia |
|
|
Abstract The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 brought back memories of the occurrence of severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002. More than 1500 MERS-CoV cases were recorded in 42 months with a case fatality rate (CFR) of 40%. Meanwhile, 8000 cases of SARS-CoV were confirmed in six months with a CFR of 10%. The clinical presentation of MERS-CoV ranges from mild and non-specific presentation to progressive and severe pneumonia. No predictive signs or symptoms exist to differentiate MERS-CoV from community-acquired pneumonia in hospitalized patients. An apparent heterogeneity was observed in transmission. Most MERS-CoV cases were secondary to large outbreaks in healthcare settings. These cases were secondary to community-acquired cases, which may also cause family outbreaks. Travel-associated MERS infection remains low. However, the virus exhibited a clear tendency to cause large outbreaks outside the Arabian Peninsula as exemplified by the outbreak in the Republic of Korea. In this review, we summarize the current knowledge about MERS-CoV and highlight travel-related issues.
|
Keywords
coronavirus
MERS
Middle East respiratory syndrome
|
Corresponding Author(s):
Ziad A. Memish
|
Just Accepted Date: 12 April 2016
Online First Date: 04 May 2016
Issue Date: 27 May 2016
|
|
1 |
JA Al-Tawfiq, A Zumla, ZA Memish. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014; 12(5): 422–428
https://doi.org/10.1016/j.tmaid.2014.06.007
pmid: 25047726
|
2 |
JA Al-Tawfiq, A Zumla, ZA Memish. Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr Opin Infect Dis 2014; 27(5): 411–417
https://doi.org/10.1097/QCO.0000000000000089
pmid: 25033169
|
3 |
Word Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) — Kuwait.
|
4 |
C Drosten, D Muth, VM Corman, R Hussain, M Al Masri, W HajOmar, O Landt, A Assiri, I Eckerle, A Al Shangiti, JA Al-Tawfiq, A Albarrak, A Zumla, A Rambaut, ZA Memish. An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis 2015; 60(3): 369–377
https://doi.org/10.1093/cid/ciu812
pmid: 25323704
|
5 |
IK Oboho, SM Tomczyk, AM Al-Asmari, AA Banjar, H Al-Mugti, MS Aloraini, KZ Alkhaldi, EL Almohammadi, BM Alraddadi, SI Gerber, DL Swerdlow, JT Watson, TA Madani. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med 2015; 372(9): 846–854
https://doi.org/10.1056/NEJMoa1408636
pmid: 25714162
|
6 |
WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) — Republic of Korea.
|
7 |
FluTrackers. South Korea Coronavirus MERS Case List—including imported and exported cases.
|
8 |
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV): summary and risk assessment of current situation in the Republic of Korea and China —as of 19 June 2015.
|
9 |
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV): WHO statement on the tenth meeting of the IHR Emergency Committee regarding MERS, 3 September 2015.
|
10 |
ND Wolfe, CP Dunavan, J Diamond. Origins of major human infectious diseases. Nature 2007; 447(7142): 279–283
https://doi.org/10.1038/nature05775
pmid: 17507975
|
11 |
The Economic and Social Impact of Emerging Infectious Disease. Mitigation through Detection, Research, and Response.
|
12 |
ZA Memish, R Alhakeem, GM Stephens. Saudi Arabia and the emergence of a novel coronavirus. East Mediterr Health J 2013; 19(Suppl 1): S7–S11
pmid: 23888789
|
13 |
AM Zaki, S van Boheemen, TM Bestebroer, AD Osterhaus, RA Fouchier. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367(19): 1814–1820
https://doi.org/10.1056/NEJMoa1211721
pmid: 23075143
|
14 |
JA Al-Tawfiq, ZA Memish. An update on Middle East respiratory syndrome: 2 years later. Expert Rev Respir Med 2015; 9(3): 327–335
https://doi.org/10.1586/17476348.2015.1027689
pmid: 25790840
|
15 |
AJ Hall, JI Tokars, SA Badreddine, ZB Saad, E Furukawa, M Al Masri, LM Haynes, SI Gerber, DT Kuhar, C Miao, SU Trivedi, MA Pallansch, R Hajjeh, ZA Memish. Health care worker contact with MERS patient, Saudi Arabia. Emerg Infect Dis 2014; 20(12): 2148–2151
https://doi.org/10.3201/eid2012.141211
pmid: 25418612
|
16 |
ZA Memish, N Mishra, KJ Olival, SF Fagbo, V Kapoor, JH Epstein, R Alhakeem, A Durosinloun, M Al Asmari, A Islam, A Kapoor, T Briese, P Daszak, AA Al Rabeeah, WI Lipkin. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 2013; 19(11): 1819–1823
https://doi.org/10.3201/eid1911.131172
pmid: 24206838
|
17 |
ZA Memish, JA Al-Tawfiq, HQ Makhdoom, AA Al-Rabeeah, A Assiri, RF Alhakeem, FA AlRabiah, S Al Hajjar, A Albarrak, H Flemban, H Balkhy, M Barry, S Alhassan, S Alsubaie, A Zumla. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect 2014; 20(5): 469–474
https://doi.org/10.1111/1469-0691.12562
pmid: 24460984
|
18 |
World Health Organization. Middle East respiratory syndrome coronavirus case definition for reporting to WHO: interim case definition 14 July 2015.
|
19 |
JA Al-Tawfiq, ZA Memish. Middle East respiratory syndrome coronavirus: epidemiology and disease control measures. Infect Drug Resist 2014; 7: 281–287
pmid: 25395865
|
20 |
MA Müller, B Meyer, VM Corman, M Al-Masri, A Turkestani, D Ritz, A Sieberg, S Aldabbagh, BJ Bosch, E Lattwein, RF Alhakeem, AM Assiri, AM Albarrak, AM Al-Shangiti, JA Al-Tawfiq, P Wikramaratna, AA Alrabeeah, C Drosten, ZA Memish. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 2015; 15(5): 559–564
https://doi.org/10.1016/S1473-3099(15)70090-3
pmid: 25863564
|
21 |
ZA Memish, AI Zumla, RF Al-Hakeem, AA Al-Rabeeah, GM Stephens. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013; 368(26): 2487–2494
https://doi.org/10.1056/NEJMoa1303729
pmid: 23718156
|
22 |
AS Omrani, MA Matin, Q Haddad, D Al-Nakhli, ZA Memish, AM Albarrak. A family cluster of Middle East Respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 2013; 17(9): e668–e672
https://doi.org/10.1016/j.ijid.2013.07.001
pmid: 23916548
|
23 |
ZA Memish, M Cotten, SJ Watson, P Kellam, A Zumla, RF Alhakeem, A Assiri, AA Rabeeah, JA Al-Tawfiq. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis 2014; 23: 63–68
https://doi.org/10.1016/j.ijid.2014.03.1372
pmid: 24699184
|
24 |
M Cotten, SJ Watson, AI Zumla, HQ Makhdoom, AL Palser, SH Ong, AA Al Rabeeah, RF Alhakeem, A Assiri, JA Al-Tawfiq, A Albarrak, M Barry, A Shibl, FA Alrabiah, S Hajjar, HH Balkhy, H Flemban, A Rambaut, P Kellam, ZA Memish. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio 2014; 5(1): e01062–e13
https://doi.org/10.1128/mBio.01062-13
pmid: 24549846
|
25 |
M Cotten, SJ Watson, P Kellam, AA Al-Rabeeah, HQ Makhdoom, A Assiri, JA Al-Tawfiq, RF Alhakeem, H Madani, FA AlRabiah, S Al Hajjar, WN Al-nassir, A Albarrak, H Flemban, HH Balkhy, S Alsubaie, AL Palser, A Gall, R Bashford-Rogers, A Rambaut, AI Zumla, ZA Memish. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 2013; 382(9909): 1993–2002
https://doi.org/10.1016/S0140-6736(13)61887-5
pmid: 24055451
|
26 |
A Assiri, A McGeer, TM Perl, CS Price, AA Al Rabeeah, DA Cummings, ZN Alabdullatif, M Assad, A Almulhim, H Makhdoom, H Madani, R Alhakeem, JA Al-Tawfiq, M Cotten, SJ Watson, P Kellam, AI Zumla, ZA; KSA MERS-CoV Investigation Team. Memish Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369(5): 407–416
https://doi.org/10.1056/NEJMoa1306742
pmid: PMID:23782161
|
27 |
ZA Memish, JA Al-Tawfiq. Middle East respiratory syndrome coronavirus infection control: the missing piece? Am J Infect Control 2014; 42(12): 1258–1260
https://doi.org/10.1016/j.ajic.2014.08.003
pmid: 25465252
|
28 |
JA Al-Tawfiq, ZA Memish. Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution. Trends Microbiol 2014; 22(10): 573–579
https://doi.org/10.1016/j.tim.2014.08.001
pmid: 25178651
|
29 |
B Hijawi, M Abdallat, A Sayaydeh, S Alqasrawi, A Haddadin, N Jaarour, S Alsheikh, T Alsanouri. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J 2013; 19(Suppl 1): S12–S18
pmid: 23888790
|
30 |
MM Al-Abdallat, DC Payne, S Alqasrawi, B Rha, RA Tohme, GR Abedi, M Al Nsour, I Iblan, N Jarour, NH Farag, A Haddadin, T Al-Sanouri, A Tamin, JL Harcourt, DT Kuhar, DL Swerdlow, DD Erdman, MA Pallansch, LM Haynes, SI Gerber, N Sabri, M Al Azhari, H Khazali, M Al Maayah, A Bilbeisi, N Dawood, B Al Zubi, J Meflih, T Mounds, J Fitzner, A Eltom, A Mafi, C Miao, H Caidi, S Trivedi, S Kamili, AJ Hall, A Curns, J Moore, H Pham, C Zimmerman, E Farnon, G Giorgi, R; Jordan MERS-CoV Investigation Team Gerber. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 2014; 59(9): 1225–1233 PMID:24829216
https://doi.org/10.1093/cid/ciu359
|
31 |
MERS-Coronavirus Molecular Epidemiology and Genetic Analysis— Origin and Evolution.
|
32 |
SK Lau, KS Li, AK Tsang, CS Lam, S Ahmed, H Chen, KH Chan, PC Woo, KY Yuen. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 2013; 87(15): 8638– 8650
https://doi.org/10.1128/JVI.01055-13
pmid: 23720729
|
33 |
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update as of 9 May 2014.
|
34 |
World health organization. Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV in Republic of Korea at a glance.
|
35 |
BJ Cowling, M Park, VJ Fang, P Wu, GM Leung, JT Wu. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill 2015; 20(25): 7–13
https://doi.org/10.2807/1560-7917.ES2015.20.25.21163
|
36 |
M Saad, AS Omrani, K Baig, A Bahloul, F Elzein, MA Matin, MA Selim, M Al Mutairi, D Al Nakhli, AY Al Aidaroos, N Al Sherbeeni, HI Al-Khashan, ZA Memish, AM Albarrak. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014; 29: 301–306
https://doi.org/10.1016/j.ijid.2014.09.003
pmid: 25303830
|
37 |
JA Al-Tawfiq, K Hinedi, J Ghandour, H Khairalla, S Musleh, A Ujayli, ZA Memish. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 2014; 59(2): 160–165
https://doi.org/10.1093/cid/ciu226
pmid: 24723278
|
38 |
YM Arabi, AA Arifi, HH Balkhy, H Najm, AS Aldawood, A Ghabashi, H Hawa, A Alothman, A Khaldi, B Al Raiy. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160(6): 389–397
https://doi.org/10.7326/M13-2486
pmid: 24474051
|
39 |
A Assiri, JA Al-Tawfiq, AA Al-Rabeeah, FA Al-Rabiah, S Al-Hajjar, A Al-Barrak, H Flemban, WN Al-Nassir, HH Balkhy, RF Al-Hakeem, HQ Makhdoom, AI Zumla, ZA Memish. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13(9): 752–761
https://doi.org/10.1016/S1473-3099(13)70204-4
pmid: 23891402
|
40 |
S Shalhoub, F Farahat, A Al-Jiffri, R Simhairi, O Shamma, N Siddiqi, A Mushtaq. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother 2015; 70(7): 2129–2132
pmid: 25900158
|
41 |
Who Mers-Cov Research Group. Stat e of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr 2013 Nov 12; 5. pii: ecurrents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8
https://doi.org/10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8
|
42 |
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update–as of 20 January 2014.
|
43 |
ZA Memish, JA Al-Tawfiq, HQ Makhdoom, A Assiri, RF Alhakeem, A Albarrak, S Alsubaie, AA Al-Rabeeah, WH Hajomar, R Hussain, AM Kheyami, A Almutairi, EI Azhar, C Drosten, SJ Watson, P Kellam, M Cotten, A Zumla. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis 2014; 210(10): 1590–1594
https://doi.org/10.1093/infdis/jiu292
pmid: 24837403
|
44 |
World Health Organization. Revised case definition for reporting to WHO— Middle East respiratory syndrome coronavirus.
|
45 |
CDC European. Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV) 21st update, 21 October 2015.
|
46 |
World Health Organization. IHR Emergency Committee concerning Middle East respiratory syndrome coronavirus.
|
47 |
World Health Organization. Report on Sep 2, 2015 meeting
|
48 |
T Soliman, AR Cook, RJ Coker. Pilgrims and MERS-CoV: what’s the risk? Emerg Themes Epidemiol 2015; 12(1): 3
https://doi.org/10.1186/s12982-015-0025-8
pmid: 25717340
|
49 |
J Lessler, I Rodriguez-Barraquer, DA Cummings, T Garske, M Van Kerkhove, H Mills, S Truelove, R Hakeem, A Albarrak, NM Ferguson; MERS-CoV Scenario Modeling Working Group. Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014. PLoS Curr 2014 Nov 24; 6. pii: ecurrents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369
https://doi.org/10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369
|
50 |
S Sridhar, P Brouqui, P Parola, P Gautret. Imported cases of Middle East respiratory syndrome: an update. Travel Med Infect Dis 2015; 13(1): 106–109
https://doi.org/10.1016/j.tmaid.2014.11.006
pmid: 25477148
|
51 |
A Zumla, P Mwaba, M Bates, JA Al-Tawfiq, M Maeurer, ZA Memish. The Hajj pilgrimage and surveillance for Middle East Respiratory syndrome coronavirus in pilgrims from African countries. Trop Med Int Health 2014; 19(7): 838–840
https://doi.org/10.1111/tmi.12318
pmid: 24750482
|
52 |
A Annan, M Owusu, KS Marfo, R Larbi, FN Sarpong, Y Adu-Sarkodie, J Amankwa, S Fiafemetsi, C Drosten, E Owusu-Dabo, I Eckerle. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health 2015; 20(6): 807–812
https://doi.org/10.1111/tmi.12482
pmid: 25688471
|
53 |
P Gautret, R Charrel, S Benkouiten, K Belhouchat, A Nougairede, T Drali, N Salez, ZA Memish, M Al Masri, JC Lagier, M Million, D Raoult, P Brouqui, P Parola. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis 2014; 20(4): 728–730
https://doi.org/10.3201/eid2004.131708
pmid: 24656283
|
54 |
ZA Memish, A Assiri, M Almasri, RF Alhakeem, A Turkestani, AA Al Rabeeah, JA Al-Tawfiq, A Alzahrani, E Azhar, HQ Makhdoom, WH Hajomar, AM Al-Shangiti, S Yezli. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 2014; 210(7): 1067–1072
https://doi.org/10.1093/infdis/jiu150
pmid: 24620019
|
55 |
S Gierer, H Hofmann-Winkler, WH Albuali, S Bertram, AM Al-Rubaish, AA Yousef, AN Al-Nafaie, AK Al-Ali, OE Obeid, KR Alkharsah, S Pöhlmann. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg Infect Dis 2013; 19(12): 2034–2036
https://doi.org/10.3201/eid1912.130701
pmid: 24274664
|
56 |
C Drosten, B Meyer, MA Müller, VM Corman, M Al-Masri, R Hossain, H Madani, A Sieberg, BJ Bosch, E Lattwein, RF Alhakeem, AM Assiri, W Hajomar, AM Albarrak, JA Al-Tawfiq, AI Zumla, ZA Memish. Transmission of MERS-coronavirus in household contacts. N Engl J Med 2014; 371(9): 828–835
https://doi.org/10.1056/NEJMoa1405858
pmid: 25162889
|
57 |
N van Doremalen, T Bushmaker, VJ Munster. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 2013; 18(38): 20590
https://doi.org/10.2807/1560-7917.ES2013.18.38.20590
pmid: 24084338
|
58 |
I Leclercq, C Batéjat, AM Burguière, JC Manuguerra . Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza Other Respi Viruses 2014; 8(5): 585–586
https://doi.org/10.1111/irv.12261
|
59 |
WHO. Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care.
|
60 |
ECDC.
|
61 |
CDC. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus. MERSCoV 15 May 2014.
|
62 |
CM Coleman, MB Frieman. Treating MERS-CoV during an outbreak. Lancet Infect Dis 2014; 14(11): 1030–1031
https://doi.org/10.1016/S1473-3099(14)70939-9
pmid: 25278219
|
63 |
H Momattin, K Mohammed, A Zumla, ZA Memish, JA Al-Tawfiq. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)—possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis 2013; 17(10): e792–e798
https://doi.org/10.1016/j.ijid.2013.07.002
pmid: 23993766
|
64 |
JA Al-Tawfiq, H Momattin, J Dib, ZA Memish. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis 2014; 20: 42–46
https://doi.org/10.1016/j.ijid.2013.12.003
pmid: 24406736
|
65 |
AS Omrani, MM Saad, K Baig, A Bahloul, M Abdul-Matin, AY Alaidaroos, GA Almakhlafi, MM Albarrak, ZA Memish, AM Albarrak. Ribavirin and interferon α-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 2014; 14(11): 1090–1095
https://doi.org/10.1016/S1473-3099(14)70920-X
pmid: 25278221
|
66 |
A Zumla, ZA Memish, M Maeurer, M Bates, P Mwaba, JA Al-Tawfiq, DW Denning, FG Hayden, DS Hui. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infect Dis 2014; 14(11): 1136–1149
https://doi.org/10.1016/S1473-3099(14)70828-X
pmid: 25189352
|
67 |
D Falzarano, E de Wit, AL Rasmussen, F Feldmann, A Okumura, DP Scott, D Brining, T Bushmaker, C Martellaro, L Baseler, AG Benecke, MG Katze, VJ Munster, H Feldmann. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 2013; 19(10): 1313–1317
https://doi.org/10.1038/nm.3362
pmid: 24013700
|
68 |
JF Chan, KH Chan, RY Kao, KK To, BJ Zheng, CP Li, PT Li, J Dai, FK Mok, H Chen, FG Hayden, KY Yuen. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 2013; 67(6): 606–616
https://doi.org/10.1016/j.jinf.2013.09.029
pmid: 24096239
|
69 |
D Falzarano , E de Wit , C Martellaro , J Callison , VJ Munster , H Feldmann . Inhibition of novel coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 2013; 3: 1686
|
70 |
JF Chan, KH Chan, RY Kao, KK To, BJ Zheng, CP Li, PT Li, J Dai, FK Mok, H Chen, FG Hayden, KY Yuen. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 2013; 67(6): 606–616
https://doi.org/10.1016/j.jinf.2013.09.029
pmid: 24096239
|
71 |
JF Chan, Y Yao, ML Yeung, W Deng, L Bao, L Jia, F Li, C Xiao, H Gao, P Yu, JP Cai, H Chu, J Zhou, H Chen, C Qin, KY Yuen. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis 2015; 212(12): 1904–1913
https://doi.org/10.1093/infdis/jiv392
pmid: 26198719
|
72 |
UJ Kim, EJ Won, SJ Kee, SI Jung, HC Jang. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome: a case report. Antivir Ther 2015 Oct 22. [Epub ahead of print]
https://doi.org/10.3851/IMP3002
pmid: PMID:26492219
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|